Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study
lurbinectedin 作为进行性恶性胸膜间皮瘤 (MPM) 姑息化疗的长期益处：SAKK 17/16 研究的最终疗效和转化数据
期刊:ESMO Open
影响因子:7.1
doi:10.1016/j.esmoop.2022.100446
M Mark, S Rusakiewicz, M Früh, S Hayoz, F Grosso, M Pless, P Zucali, G L Ceresoli, A Maconi, M Schneider, P Froesch, D Tarussio, F Benedetti, J Dagher, L Kandalaft, R von Moos, S Tissot-Renaud, S Schmid, Y Metaxas
